Literature DB >> 35987965

The origin and continuing adaptive evolution of chikungunya virus.

Mohamad S Hakim1, Luthvia Annisa2, Faris M Gazali3, Abu T Aman2.   

Abstract

Chikungunya virus (CHIKV) is the responsible agent of chikungunya fever, a debilitating arthritic disease in humans. CHIKV is endemic in Africa and Asia, although transmission cycles are considerably different on these continents. Before 2004, CHIKV had received little attention, since it was only known to cause localised outbreaks in a limited region with no fatalities. However, the recent global reemergence of CHIKV has caused serious global health problems and shown its potential to become a significant viral threat in the future. Unexpectedly, the reemergence is more rapid and is geographically more extensive, especially due to increased intensity of global travel systems or failure to contain mosquito populations. Another important factor is the successful adaptation of CHIKV to a new vector, the Aedes albopictus mosquito. Ae. albopictus survives in both temperate and tropical climates, thus facilitating CHIKV expansion to non-endemic regions. The continuous spread and transmission of CHIKV pose challenges for the development of effective vaccines and specific antiviral therapies. In this review, we discuss the biology and origin of CHIKV in Africa as well as its subsequent expansion to other parts of the world. We also review the transmission cycle of CHIKV and its continuing adaptation to its mosquito vectors and vertebrate hosts. More-complete understanding of the continuous evolution of CHIKV may help in predicting the emergence of CHIKV strains with possibly greater transmission efficiency in the future.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Year:  2022        PMID: 35987965     DOI: 10.1007/s00705-022-05570-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.685


  120 in total

1.  Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site.

Authors:  Afjal Hossain Khan; Kouichi Morita; Maria Del Carmen Parquet; Futoshi Hasebe; Edward G M Mathenge; Akira Igarashi
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

Review 2.  Epidemic arboviral diseases: priorities for research and public health.

Authors:  Annelies Wilder-Smith; Duane J Gubler; Scott C Weaver; Thomas P Monath; David L Heymann; Thomas W Scott
Journal:  Lancet Infect Dis       Date:  2016-12-21       Impact factor: 25.071

Review 3.  Arboviruses: A Family on the Move.

Authors:  Paul R Young
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 4.  Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses.

Authors:  Ali Zaid; Felicity J Burt; Xiang Liu; Yee Suan Poo; Keivan Zandi; Andreas Suhrbier; Scott C Weaver; Mauro M Texeira; Suresh Mahalingam
Journal:  Lancet Infect Dis       Date:  2020-11-05       Impact factor: 25.071

5.  Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography.

Authors:  James E Voss; Marie-Christine Vaney; Stéphane Duquerroy; Clemens Vonrhein; Christine Girard-Blanc; Elodie Crublet; Andrew Thompson; Gérard Bricogne; Félix A Rey
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

Review 6.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Authors:  Yun Young Go; Udeni B R Balasuriya; Chong-Kyo Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

Review 7.  Emerging arboviruses: Why today?

Authors:  Ernest Gould; John Pettersson; Stephen Higgs; Remi Charrel; Xavier de Lamballerie
Journal:  One Health       Date:  2017-07-01

Review 8.  A scoping review of published literature on chikungunya virus.

Authors:  Mariola Mascarenhas; Sophiya Garasia; Philippe Berthiaume; Tricia Corrin; Judy Greig; Victoria Ng; Ian Young; Lisa Waddell
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

9.  Global transmission and evolutionary dynamics of the Chikungunya virus.

Authors:  F Deeba; M S H Haider; A Ahmed; A Tazeen; M I Faizan; N Salam; T Hussain; S F Alamery; S Parveen
Journal:  Epidemiol Infect       Date:  2020-02-19       Impact factor: 2.451

10.  Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins.

Authors:  Jose A Quiroz; Ryan J Malonis; Larissa B Thackray; Courtney A Cohen; Jesper Pallesen; Rohit K Jangra; Rebecca S Brown; Daniel Hofmann; Frederick W Holtsberg; Sergey Shulenin; Elisabeth K Nyakatura; Lorellin A Durnell; Vinayak Rayannavar; Johanna P Daily; Andrew B Ward; M Javad Aman; John M Dye; Kartik Chandran; Michael S Diamond; Margaret Kielian; Jonathan R Lai
Journal:  PLoS Pathog       Date:  2019-11-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.